Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueGross MarginInterest Coverage RatioInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

CASI Pharmaceuticals (CASI) Operating Margin (2022 - 2025)

Historic Operating Margin for Pharmaceuticals (CASI) over the last 4 years, with Q2 2025 value amounting to 266.47%.

  • Pharmaceuticals' Operating Margin fell 455800.0% to 266.47% in Q2 2025 from the same period last year, while for Jun 2025 it was 276.14%, marking a year-over-year decrease of 1602700.0%. This contributed to the annual value of 138.84% for FY2024, which is 648100.0% down from last year.
  • Latest data reveals that Pharmaceuticals reported Operating Margin of 266.47% as of Q2 2025, which was down 455800.0% from 166.33% recorded in Q1 2025.
  • In the past 5 years, Pharmaceuticals' Operating Margin ranged from a high of 49.85% in Q4 2023 and a low of 277.32% during Q1 2024
  • Moreover, its 4-year median value for Operating Margin was 90.79% (2023), whereas its average is 131.15%.
  • In the last 5 years, Pharmaceuticals' Operating Margin tumbled by -1909100bps in 2024 and then soared by 1109900bps in 2025.
  • Quarter analysis of 4 years shows Pharmaceuticals' Operating Margin stood at 145.89% in 2022, then skyrocketed by 66bps to 49.85% in 2023, then plummeted by -343bps to 220.88% in 2024, then decreased by -21bps to 266.47% in 2025.
  • Its last three reported values are 266.47% in Q2 2025, 166.33% for Q1 2025, and 220.88% during Q2 2024.